SCHEMBL246071

SCHEMBL246071

[CH2]C(OC)OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27536934 0.95
SCHEMBL996066 0.74
SCHEMBL8438168 0.73
SCHEMBL11311091 0.71
SCHEMBL6181773 0.71
SCHEMBL127598 0.70
SCHEMBL1816998 0.70
SCHEMBL1252971 0.70
SCHEMBL1067283 0.70
SCHEMBL15363944 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2421 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240239759-A1 ISOXAZOLINE COMPOSITIONS AND THEIR USE AS ANTIPARASITICS INTERVET INC. (US) 2024-07-18 US claimed
WO-2024115403-A1 NICOTINE-BASED IONIC LIQUIDS FOR WATER VAPOR REMOVAL FOUNDATION OF RESEARCH AND TECHNOLOGY HELLAS / INSTITUTE OF CHEMICAL ENGINEERING SCIENCES (GR) 2024-06-06 WO claimed
CN-111295376-B Injectable isoxazoline pharmaceutical composition and use thereof against parasite infestations 英特维特国际股份有限公司 2024-05-24 CN claimed
US-11975023-B2 Methods for inhibiting anaerobic microorganisms LPOXY THERAPEUTICS, INC (US) 2024-05-07 US claimed
EP-4358941-A1 PALATABLE VETERINARY COMPOSITIONS Intervet International B.V. (NL) 2024-05-01 EP claimed
US-20240122849-A1 ISOXAZOLINE COMPOSITIONS AND USE THEREOF IN THE PREVENTION OR TREATMENT OF PARASITE INFESTATIONS IN ANIMALS INTERVET INC. (US) 2024-04-18 US claimed
EP-4351341-A1 TICK CONTROL METHODS Intervet International B.V. (NL) 2024-04-17 EP claimed
US-11944641-B2 Treatment of inflammatory bowel diseases through administration of enteric aerobization therapy LPOXY THERAPEUTICS, INC. (US) 2024-04-02 US claimed
CN-117545473-A Palatable veterinary compositions 英特维特国际股份有限公司 2024-02-09 CN claimed
WO-2024027690-A1 INTERMEDIATE OF BICYCLIC INHIBITOR AND PREPARATION METHOD THEREFOR 江苏豪森药业集团有限公司 2024-02-08 WO claimed
US-4515783-A BACTERICIDAL ANTIBIOTICS, GROWTH PROMOTERS MERCK & CO., INC. (US) 1985-05-07 US claimed
EP-0123996-A1 N-cyclohexadienyl-chloracetamides BAYER AG (DE) 1984-11-07 EP claimed
US-4441915-A POSTEMERGENCE SCHERING AKTIENGESELLSCHAFT (DE) 1984-04-10 US claimed
EP-0101598-A1 Beta-lactams F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1984-02-29 EP claimed
EP-0094727-A2 Substituted heterocyclyl phenylformamidines, processes for their preparation and their pharmaceutical use ISTITUTO DE ANGELI S.p.A. (IT) 1983-11-23 EP claimed
US-4378318-A HERBICIDES SCHERING AKTIENGESELLSCHAFT (DE) 1983-03-29 US claimed
US-4365990-A Sulfonylurea herbicidal antidotes STAUFFER CHEMICAL COMPANY (US) 1982-12-28 US claimed
EP-0063359-A1 1,4-Dihydropyridine derivatives and processes for preparing the same BANYU PHARMACEUTICAL CO., LTD. (JP) 1982-10-27 EP claimed
US-4127720-A ANTIALLERGENS BRISTOL-MYERS COMPANY (US) 1978-11-28 US claimed
US-4123607-A BACTERICIDES AMERICAN CYANAMID COMPANY (US) 1978-10-31 US claimed